Joke Tio

1.6k total citations
33 papers, 571 citations indexed

About

Joke Tio is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Joke Tio has authored 33 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 9 papers in Cancer Research and 8 papers in Surgery. Recurrent topics in Joke Tio's work include HER2/EGFR in Cancer Research (9 papers), Breast Cancer Treatment Studies (6 papers) and Cancer Cells and Metastasis (5 papers). Joke Tio is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Breast Cancer Treatment Studies (6 papers) and Cancer Cells and Metastasis (5 papers). Joke Tio collaborates with scholars based in Germany, Greece and Switzerland. Joke Tio's co-authors include Ludwig Kiesel, P Wülfing, Christian Kersting, Ruth Ruscheweyh, Esther Pogatzki‐Zahn, Augustinus H. Tulusan, Raihanatou Diallo, W. Böcker, Christopher Poremba and Christian Wülfing and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and Clinical Cancer Research.

In The Last Decade

Joke Tio

29 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joke Tio Germany 13 202 167 144 138 94 33 571
Nobuko Tamura Japan 14 172 0.9× 122 0.7× 100 0.7× 69 0.5× 101 1.1× 39 455
Joaquim S. L. Vong Hong Kong 13 88 0.4× 161 1.0× 201 1.4× 65 0.5× 117 1.2× 16 617
Maria Fragoso Portugal 12 328 1.6× 68 0.4× 129 0.9× 108 0.8× 128 1.4× 19 507
K.-D. Schulz Germany 15 160 0.8× 111 0.7× 140 1.0× 75 0.5× 88 0.9× 31 634
Anand Desai United States 14 114 0.6× 96 0.6× 189 1.3× 138 1.0× 94 1.0× 28 617
Gholamreza Safaee Ardekani Canada 13 215 1.1× 124 0.7× 302 2.1× 60 0.4× 89 0.9× 18 554
Hilde Janssen Belgium 12 97 0.5× 186 1.1× 149 1.0× 116 0.8× 103 1.1× 36 574
Tokiko Ito Japan 12 142 0.7× 75 0.4× 57 0.4× 124 0.9× 76 0.8× 37 431
Brent Shoji United States 8 355 1.8× 100 0.6× 172 1.2× 233 1.7× 64 0.7× 8 807
Danae A. Delivanis United States 18 263 1.3× 196 1.2× 80 0.6× 531 3.8× 31 0.3× 33 1.1k

Countries citing papers authored by Joke Tio

Since Specialization
Citations

This map shows the geographic impact of Joke Tio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joke Tio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joke Tio more than expected).

Fields of papers citing papers by Joke Tio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joke Tio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joke Tio. The network helps show where Joke Tio may publish in the future.

Co-authorship network of co-authors of Joke Tio

This figure shows the co-authorship network connecting the top 25 collaborators of Joke Tio. A scholar is included among the top collaborators of Joke Tio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joke Tio. Joke Tio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lux, Michael P., Christine zu Eulenburg, Martin Smollich, et al.. (2024). App-based support for breast cancer patients to reduce psychological distress during therapy and survivorship – a multicentric randomized controlled trial. Frontiers in Oncology. 14. 1354377–1354377. 6 indexed citations
3.
Krug, David, Joke Tio, Khaled Elsayad, et al.. (2024). The Safety and Efficacy of the Combination of Sacituzumab Govitecan and Palliative Radiotherapy—A Retrospective Multi-Center Cohort Study. Cancers. 16(9). 1649–1649. 5 indexed citations
4.
Athanasiadis, Apostolos, et al.. (2024). Correction of the Tuberous Breast with Fat Grafting and Implant: Techniques, Evaluation with BREAST-Q, and Preliminary Results. Aesthetic Plastic Surgery. 48(23). 4953–4964. 1 indexed citations
5.
Tio, Joke, et al.. (2022). Treating Pain and Fat Necrosis after Breast Cancer Surgery with Fat Grafting: Is one Session Enough?. Aesthetic Plastic Surgery. 46(6). 2677–2688. 3 indexed citations
6.
Backhaus, Philipp, Matthias C. Burg, Wolfgang Roll, et al.. (2021). Simultaneous FAPI PET/MRI Targeting the Fibroblast-Activation Protein for Breast Cancer. Radiology. 302(1). 39–47. 59 indexed citations
7.
Harbeck, Nadia, Raquel von Schumann, Ronald Kates, et al.. (2021). Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer. Cancers. 13(19). 4884–4884. 10 indexed citations
8.
Goulis, Dimitrios G., et al.. (2021). Treating Anisomastia and Tuberous Breast with Fat Grafting: Technique and Evaluation of Outcomes Using BREAST-Q Surveys. Aesthetic Plastic Surgery. 45(6). 2729–2741. 11 indexed citations
9.
Goulis, Dimitrios G., et al.. (2020). Fat Grafting and Auto-Augmentation Mastopexy After Breast Implant Removal: Technique and Evaluation of Outcomes Using BREAST-Q. Aesthetic Surgery Journal. 41(6). NP388–NP401. 9 indexed citations
10.
Elsayad, Khaled, M.A.M. Meheissen, I Radke, et al.. (2020). Impact of Adjuvant Radiation Therapy in Patients With Male Breast Cancer: A Multicenter International Analysis. Advances in Radiation Oncology. 5(3). 345–349. 10 indexed citations
11.
Barth, Peter, Joke Tio, Hans‐Christian Kolberg, et al.. (2019). Correlation Between Sfrp1 Expression and Clinicopathological Parameters in Patients With Triple-Negative Breast Cancer. Future Oncology. 15(16). 1921–1938. 13 indexed citations
12.
Radke, I, et al.. (2019). Ribociclib in Breast Cancer Brain Metastases: A Case Report. Breast Care. 15(5). 543–547. 6 indexed citations
13.
Braun, Bettina, et al.. (2019). The Mode of Detection Is Not Associated with Quality of Life in Women with Breast Cancer. Breast Care. 15(5). 498–505. 2 indexed citations
14.
Bokhof, Beate, Joke Tio, I Radke, et al.. (2018). Higher Detection Rates of Biologically Aggressive Breast Cancers in Mammography Screening than in the Biennial Interval. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 191(2). 130–136. 3 indexed citations
15.
Tio, Joke, et al.. (2017). Reverse engineering of triple-negative breast cancer cells for targeted treatment. Maturitas. 108. 24–30. 3 indexed citations
16.
Agelopoulos, Konstantin, Christian Kersting, Eberhard Korsching, et al.. (2007). Egfr Amplification Specific Gene Expression in Phyllodes Tumours of the Breast. Analytical Cellular Pathology. 29(6). 443–451. 13 indexed citations
17.
Buchweitz, Olaf, Annette Staebler, Joke Tio, & Ludwig Kiesel. (2006). Detection of peritoneal endometriotic lesions by autofluorescence laparoscopy. American Journal of Obstetrics and Gynecology. 195(4). 949–954. 20 indexed citations
18.
Kersting, Christian, Arno Kuijper, Hartmut Schmidt, et al.. (2005). Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression. Laboratory Investigation. 86(1). 54–61. 57 indexed citations
19.
Eggers, Verena, Joke Tio, Tim Neumann, et al.. (2002). Blood alcohol concentration for monitoring ethanol treatment to prevent alcohol withdrawal in the intensive care unit. Intensive Care Medicine. 28(10). 1475–1482. 31 indexed citations
20.
Bader, Arnim, Joke Tio, Edgar Petru, et al.. (2002). T1 Breast Cancer: Identification of Patients at Low Risk of Axillary Lymph Node Metastases. Breast Cancer Research and Treatment. 76(1). 11–17. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobuko Tamura Breakdown of academic impact, for papers by Joaquim S. L. Vong Breakdown of academic impact, for papers by Maria Fragoso Breakdown of academic impact, for papers by K.-D. Schulz Breakdown of academic impact, for papers by Anand Desai Breakdown of academic impact, for papers by Gholamreza Safaee Ardekani Breakdown of academic impact, for papers by Hilde Janssen Breakdown of academic impact, for papers by Tokiko Ito Breakdown of academic impact, for papers by Brent Shoji Breakdown of academic impact, for papers by Danae A. Delivanis
Rankless by CCL
2026